Latest news
Spyre Therapeutics Launches Program, Mid-Stage Trial for Drug Combination to Treat Hidradenitis Suppurativa - marketscreener.commarketscreener.com · Mon, 10 Aug 2026 14:05:51 GMTProbiotics in Hidradenitis Suppurativa: Biologic Rationale vs. Clinical Evidence - Dermatology TimesDermatology Times · Mon, 10 Aug 2026 13:10:20 GMTSpyre Therapeutics Announces Launch of SPY772 Program and Initiation of Phase 2 SKYLIGHT Trial in Hidradenitis Suppurativa - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 12:21:27 GMTAdalimumab grabs top spot as most cost-efficient biologic for hidradenitis suppurativa - Managed Healthcare ExecutiveManaged Healthcare Executive · Thu, 06 Aug 2026 01:24:08 GMTPsoriasiform Dermatitis Following JAK Inhibitor Therapy for Hidradenitis Suppurativa and Crohn’s Disease - CureusCureus · Wed, 05 Aug 2026 16:26:24 GMTMerck's anti-TL1A antibody scores a win in hidradenitis suppurativa, fails in a rare lung disease - Endpoints NewsEndpoints News · Tue, 04 Aug 2026 10:30:00 GMTMerck’s $11B anti-TL1A bet delivers 1 win, 1 loss in midphase inflammatory disease trials - Fierce BiotechFierce Biotech · Tue, 04 Aug 2026 10:30:00 GMTPovorcitinib beneficial for moderate-to-severe hidradenitis suppurativa - Medical XpressMedical Xpress · Wed, 29 Jul 2026 01:20:01 GMT